Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Open: Sep 2, 13:29 PM 2010 
  NYSE  6926.96  15.98  Index Moved Up   NASDAQ  2186.38  9.54  Index Moved Up 
 { and more.. }
Search is sponsered by  
  



Processing
Collecting necessary data for SLXP and PRGO...

    
SLXP  Salix Pharmaceuticals Ltd.  vs  PRGO  Perrigo Co.
    

   ProfileMedia
39.69
  
Salix Quote
Intraday
 
Salix Intraday Quote
One Month
 0.59   Macroaxis: 1.51 Up   1.51%  
Salix Quote: BullSLXP Macroaxis: United States NASDAQ
Salix Pharmaceuticals Ltd.
 
Market Cap 2.295B   Book Value 6.472   EBITDA -12.0M   PEG Ratio 29.94   EPS -1.178   P/B Ratio 6.04   Short Ratio 6.50   Index Membership S&P   Sector Healthcare   Full Time Employees 395   Profile Get Profile for:   Drug Related Products   Open 39.06   High 39.75   Low 38.98   Volume 233.4 K   Target Price 50.60   Current EPS -1.178   This Year EPS 0.03   Next Year EPS 1.55   This Year PE 1303.33   Next Year PE 25.23  
    
    
    
Symbol  SLXP
Name  Salix Pharmaceuticals Ltd.
TypeStock
Country  Macroaxis: United States United States
Exchange  NASDAQ
 
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States.
    

Company Summary   more 

    
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor...
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or short-term therapy for adults; Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis; Anusol-HC and Proctocort, the hydrocortisone creams and suppositories for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and inflammatory conditions; Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications that include the treatment of duodenal ulcer, benign gastric ulcer, and gastro esophageal reflux diseases; and Colazal capsules for the treatment of ulcerative colitis. In addition, Salix has products under development for the treatment of hepatic encephalopathy and irritable bowel syndrome, HIV-associated diarrhea, gastroenterology, and ulcerative proctitis or proctosigmoiditis. It has collaboration agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; Biorex Laboratories Limited; Cedars?Sinai Medical Center; Clinical Development Capital Partnership; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Lupin, Ltd.; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Norgine B.V.; and Wilmington Pharmaceuticals, LLC. The company was founded in 1989 and is headquartered in Morrisville, North Carolina.
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor...
    

Top Stories

 
 
 
 
 

Community Discussions

        
  
57.8
  
Perrigo Quote
Intraday
 
Perrigo Intraday Quote
One Month
(0.19)  Macroaxis: -0.33 Down   0.33%  
Perrigo Quote: BearPRGO Macroaxis: United States NASDAQ
Perrigo Co.
 
Market Cap 5.300B   Book Value 11.853   EBITDA 450.4M   PEG Ratio 1.48   EPS 2.397   P/E 24.19   P/B Ratio 4.89   Short Ratio 3.80   Index Membership S&P   Sector Healthcare   Full Time Employees 7,700   Profile Get Profile for:   Drug Related Products   Open 58.12   High 58.48   Low 57.71   Volume 269.7 K   Target Price 63.14   Current EPS 2.397   This Year EPS 3.40   Next Year EPS 3.79   Current PE 24.19   This Year PE 17.06   Next Year PE 15.30   Dividend 0.252   Dividend Yield 0.43   Dividend Date Sep 14  
    
    
    
Symbol  PRGO
Name  Perrigo Co.
TypeStock
Country  Macroaxis: United States United States
Exchange  NASDAQ
 
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and medical diagnostic products worldwide.
    

Company Summary   more 

    
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and medical diagnostic products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products. The Rx Pharmaceuticals segment develops, manufactures, and markets generic prescription drug products, including creams, o...
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and medical diagnostic products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products. The Rx Pharmaceuticals segment develops, manufactures, and markets generic prescription drug products, including creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquid suspensions, and solutions, as well as nasal sprays, oral liquids, and transdermal products. The API segment engages in the development, manufacture, and marketing of APIs used by the generic drug industry and branded pharmaceutical companies. Perrigo Company also manufactures and markets branded prescription drugs; and imports pharmaceutical, diagnostics, and other medical products. The company has collaborative agreements with Medicis Pharmaceutical Corporation, Medimetriks Pharmaceuticals, Cobrek Pharmaceuticals, and Cephalon Inc. Its customers primarily include retail drug companies, supermarkets, wholesalers, chain drug stores, hospitals and hospital systems, mass merchandise chains, and group purchasing organizations. The company was founded in 1887 and is headquartered in Allegan, Michigan.
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and medical diagnostic products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products. The Rx Pharmaceuticals segment develops, manufactures, and markets generic prescription drug products, including creams, o...
    

Top Stories

 
 
 
 

Community Discussions